| 查看: 1627 | 回复: 4 | |||
[交流]
美国南密西西比大学 白逢伟教授课题组诚招病毒感染免疫方向的优秀硕博士(免学费)
|
|
Dr. Fengwei Bai’s laboratory in the Department of Biological Sciences at The University of Southern Mississippi (Hattiesburg, MS, USA) is look for a self-motived and hardworking Ph.D candidate to study the pathogensis of Zika virus, West Nile virus and dengue virus in mouse models, and to develop vaccines and anti-viral reagents. The Ph.D position will start from the fall semester 2018. Dr. Bai’s research is supported by grants from the NIH, American Heart Association and other funding agencies. The laboratory currently has three graduate students (two Ph.D and one master student). The lab research environment is very friendly, collaborative and productive. In last five years, Dr. Bai and his students published over 20 research articles in Journal of Immunology, Journal of Virology, Journal of Biological chemistry, Scientific Reports and etc.. Two recently graduated Ph.D students were recruited as postdoctoral fellows by the US National Aeronautics and Space Administration (NASA) and University of Chicago, respectively. The benefits of graduate students in the Department of Biological Sciences include tuition waiver, RA or TA support, and free health insurance. The basic qualification of a candidate must have a BS or a master degree in biology, medicine or other related fields with strong interests in study of Virology, Immunology and infectious diseases. For detail information regarding Dr. Bai’s research, please visit: https://www.usm.edu/biological-sciences/faculty/fengwei-bai Information regarding The University of Southern Mississippi: https://home.usm.edu Information regarding the city Hattiesburg: https://www.hattiesburgms.com Interested candidates please contact Dr. Fengwei Bai: Fengwei.bai@usm.edu |
» 猜你喜欢
申博/考博
已经有5人回复
申博
已经有3人回复
湖南大学刘巧玲课题组2026年第二批次博士研究生招生信息
已经有5人回复
求计算机方向调剂
已经有6人回复
通信工程求调剂!!!
已经有7人回复
26药学专硕105500求调剂
已经有8人回复
297,工科调剂?
已经有11人回复
申博自荐
已经有4人回复
294求调剂
已经有9人回复
291求调剂
已经有11人回复
2楼2017-11-04 02:51:50
3楼2017-11-04 19:57:34

4楼2017-11-06 17:14:34
5楼2017-11-09 03:32:27













回复此楼